Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition
NCT01888731
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Lamotrigine
Sponsor
Dr. Reddy's Laboratories Limited